Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Reletrans 25microgram/hour transdermal patches
0407020B0BKAEAL
|
Reletrans | Buprenorphine | Central Nervous System | 207 |
|
Reletrans 30micrograms/hour transdermal patches
0407020B0BKAFAM
|
Reletrans | Buprenorphine | Central Nervous System | 141 |
|
Panitaz 5micrograms/hour transdermal patches
0407020B0BLAAAH
|
Panitaz | Buprenorphine | Central Nervous System | 118 |
|
Carlosafine 35micrograms/hour transdermal patches
0407020B0BTAAAE
|
Carlosafine | Buprenorphine | Central Nervous System | 113 |
|
Buprenorphine 40micrograms/hour transdermal patches
0407020B0AAANAN
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 91 |
|
Carlosafine 70micrograms/hour transdermal patches
0407020B0BTACAG
|
Carlosafine | Buprenorphine | Central Nervous System | 59 |
|
Carlosafine 52.5micrograms/hour transdermal patches
0407020B0BTABAF
|
Carlosafine | Buprenorphine | Central Nervous System | 56 |
|
Reletrans 40micrograms/hour transdermal patches
0407020B0BKAGAN
|
Reletrans | Buprenorphine | Central Nervous System | 56 |
|
Tephine 400microgram sublingual tablets
0407020B0BFABAD
|
Tephine | Buprenorphine | Central Nervous System | 48 |
|
Bupramyl 5micrograms/hour transdermal patches
0407020B0BQAAAH
|
Bupramyl | Buprenorphine | Central Nervous System | 19 |
|
Buplast 70micrograms/hour transdermal patches
0407020B0BNACAG
|
Buplast | Buprenorphine | Central Nervous System | 11 |
|
Bupramyl 10micrograms/hour transdermal patches
0407020B0BQABAI
|
Bupramyl | Buprenorphine | Central Nervous System | 6 |
|
Bupramyl 20micrograms/hour transdermal patches
0407020B0BQACAJ
|
Bupramyl | Buprenorphine | Central Nervous System | 4 |
|
Turgeon 35micrograms/hour transdermal patches
0407020B0BSAAAE
|
Turgeon | Buprenorphine | Central Nervous System | 4 |
|
Buplast 35micrograms/hour transdermal patches
0407020B0BNAAAE
|
Buplast | Buprenorphine | Central Nervous System | 3 |
|
Bunov 15micrograms/hour transdermal patches
0407020B0BUADAK
|
Bunov | Buprenorphine | Central Nervous System | No data available |
|
Bunov 30micrograms/hour transdermal patches
0407020B0BUAEAM
|
Bunov | Buprenorphine | Central Nervous System | No data available |
|
Bunov 40micrograms/hour transdermal patches
0407020B0BUAFAN
|
Bunov | Buprenorphine | Central Nervous System | No data available |
|
Buplast 52.5micrograms/hour transdermal patches
0407020B0BNABAF
|
Buplast | Buprenorphine | Central Nervous System | No data available |
|
Buprenorphine 300micrograms/1ml inj ampoules
0407020B0AAAAAA
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | No data available |
|
Busiete 10micrograms/hour transdermal patches
0407020B0BRABAI
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Busiete 20micrograms/hour transdermal patches
0407020B0BRACAJ
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Busiete 5micrograms/hour transdermal patches
0407020B0BRAAAH
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Prenotrix 35micrograms/hour transdermal patches
0407020B0BJAAAE
|
Prenotrix | Buprenorphine | Central Nervous System | No data available |
|
Prenotrix 52.5micrograms/hour transdermal patches
0407020B0BJABAF
|
Prenotrix | Buprenorphine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.